Annual EBITDA
-$47.82 M
-$18.26 M-61.78%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual EBITDA is -$47.82 million, with the most recent change of -$18.26 million (-61.78%) on December 31, 2023.
- During the last 3 years, DNTH annual EBITDA has fallen by -$34.73 million (-265.42%).
- DNTH annual EBITDA is now -265.42% below its all-time high of -$13.09 million, reached on December 31, 2021.
Performance
DNTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$29.78 M
-$7.69 M-34.81%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly EBITDA is -$29.78 million, with the most recent change of -$7.69 million (-34.81%) on September 30, 2024.
- Over the past year, DNTH quarterly EBITDA has dropped by -$14.11 million (-90.05%).
- DNTH quarterly EBITDA is now -291.79% below its all-time high of -$7.60 million, reached on March 1, 2023.
Performance
DNTH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$82.47 M
-$14.11 M-20.65%
September 30, 2024
Summary
- As of February 7, 2025, DNTH TTM EBITDA is -$82.47 million, with the most recent change of -$14.11 million (-20.65%) on September 30, 2024.
- Over the past year, DNTH TTM EBITDA has dropped by -$36.86 million (-80.81%).
- DNTH TTM EBITDA is now -899.12% below its all-time high of -$8.25 million, reached on September 30, 2022.
Performance
DNTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNTH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.8% | -90.0% | -80.8% |
| 3 y3 years | -265.4% | -90.0% | -80.8% |
| 5 y5 years | -265.4% | -90.0% | -80.8% |
DNTH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -265.4% | at low | -291.8% | at low | -899.1% | at low |
| 5 y | 5-year | -265.4% | at low | -291.8% | at low | -899.1% | at low |
| alltime | all time | -265.4% | at low | -291.8% | at low | -899.1% | at low |
Dianthus Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.78 M(+34.8%) | -$82.47 M(+20.6%) |
| Jun 2024 | - | -$22.09 M(+24.6%) | -$68.36 M(+17.9%) |
| Mar 2024 | - | -$17.74 M(+38.0%) | -$57.95 M(+21.2%) |
| Dec 2023 | -$47.82 M | -$12.85 M(-18.0%) | -$47.82 M(+4.8%) |
| Sep 2023 | - | -$15.67 M(+34.0%) | -$45.61 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$11.69 M(+53.8%) | -$38.19 M(+44.1%) |
| Mar 2023 | - | -$7.60 M(-28.6%) | -$26.50 M(+40.2%) |
| Dec 2022 | -$29.56 M(+125.9%) | -$10.64 M(+29.0%) | -$18.90 M(+129.0%) |
| Sep 2022 | - | -$8.25 M | -$8.25 M |
| Dec 2021 | -$13.09 M | - | - |
FAQ
- What is Dianthus Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual EBITDA year-on-year change?
- What is Dianthus Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly EBITDA year-on-year change?
- What is Dianthus Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Dianthus Therapeutics?
- What is Dianthus Therapeutics TTM EBITDA year-on-year change?
What is Dianthus Therapeutics annual EBITDA?
The current annual EBITDA of DNTH is -$47.82 M
What is the all time high annual EBITDA for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual EBITDA is -$13.09 M
What is Dianthus Therapeutics annual EBITDA year-on-year change?
Over the past year, DNTH annual EBITDA has changed by -$18.26 M (-61.78%)
What is Dianthus Therapeutics quarterly EBITDA?
The current quarterly EBITDA of DNTH is -$29.78 M
What is the all time high quarterly EBITDA for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly EBITDA is -$7.60 M
What is Dianthus Therapeutics quarterly EBITDA year-on-year change?
Over the past year, DNTH quarterly EBITDA has changed by -$14.11 M (-90.05%)
What is Dianthus Therapeutics TTM EBITDA?
The current TTM EBITDA of DNTH is -$82.47 M
What is the all time high TTM EBITDA for Dianthus Therapeutics?
Dianthus Therapeutics all-time high TTM EBITDA is -$8.25 M
What is Dianthus Therapeutics TTM EBITDA year-on-year change?
Over the past year, DNTH TTM EBITDA has changed by -$36.86 M (-80.81%)